Measuring anxiety disorder in bipolar disorder using EVestG: broad impact of medication groups.

ABSTRACT:

Objectives

Anxiety disorder is present in approximately half of all bipolar disorder (BD) patients. There are neurologic bases for the comorbidity of balance (vestibular) disorders and anxiety. Our objective is to use electrovestibulography (EVestG), which is predominantly a measure of vestibular neural activity to not only quantitatively detect and measure comorbid anxiety disorder but also to quantitatively measure the impacts of anti-depressant, anti-psychotic, and mood stabilizer medication groups on anxiety measures in BD patients.

Methods

In a population of 50 (24 with anxiety disorder) depressive phase BD patients, EVestG signals were measured. Participants were labeled depression-wise as anxious or non-anxious using standard questionnaires. Analyses were conducted on

SUBMITTER: Lithgow BJ 

PROVIDER: S-EPMC10824993 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature